Novel Therapeutic Approach With PAC ‐14028 Cream, a TRPV 1 Antagonist, for Patients With Mild‐to‐moderate Atopic Dermatitis

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.17777
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

PAC‐14028 Cream for Atopic Dermatitis

British Journal of Dermatology
DermatologyMedicine
2019English

Evaluation of a Pseudoceramide Moisturizer in Patients With Mild-To-Moderate Atopic Dermatitis

Dermatology and Therapy
Dermatology
2014English

Ruxolitinib Cream Suppresses Th2 Inflammation in Adult Patients With Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Mild Topical Steroid Leads to Progressive Anti-Inflammatory Effects in the Skin of Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

New Cosmetic Formulation for the Treatment of Mild to Moderate Infantile Atopic Dermatitis

Children
2019English

Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Cutaneous Medicine and Surgery
DermatologySurgery
2018English

Long-Term Safety of Crisaborole Ointment 2% in Children and Adults With Mild-To-Moderate Atopic Dermatitis

Pediatrics
Child HealthPediatricsPerinatology
2018English

605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Systemic Exposure, Tolerability, and Efficacy of Pimecrolimus Cream 1% in Atopic Dermatitis Patients

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy